₹64.8*
MRP ₹72
10% off
₹61.2*
MRP ₹72
15% CB
₹10.8 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Available Offers
PHARMA18PHARMA10PHARMA20
Prescription drugWhats That
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Extra Savings
Composition :
Manufacturer/Marketer :
Consume Type :
Return Policy :
Expires on or after :
Drug-Drug Interactions
Drug-Drug Interactions
Login/Sign Up
Combining Sodium phenylbutyrate and Valeptol Solution 100 ml can increase ammonia levels in the blood.
How to manage the interaction:
Taking Sodium phenylbutyrate with Valeptol Solution 100 ml is not recommended, but it can be taken if prescribed by a doctor. If you experience any symptoms like sudden dizziness, lightheadedness, fainting, headache, shortness of breath, nausea, vomiting, chest pain or tightness, rapid heartbeat, or memory loss, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
Co-administration of Leflunomide and Valeptol Solution 100 ml can increase the risk of causing liver problems.
How to manage the interaction:
Co-administration of Leflunomide and Valeptol Solution 100 ml can lead to an interaction, they can be taken together if prescribed by a doctor. However, if you experience fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, less desire to eat, fatigue, nausea, vomiting, abdominal pain, or yellowing of the skin or eyes, contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
Co-administration of Lithium with Valeptol Solution 100 ml can increase the risk irregular heart rhythm.
How to manage the interaction:
Co-administration of Lithium and Valeptol Solution 100 ml can lead to an interaction, but it can be taken if advised by your doctor. However, consult your doctor immediately if you experience any symptoms like dizziness, drowsiness, confusion, lightheadedness, fainting, shortness of breath, chest pain or tightness, rapid heartbeat, and difficulty concentrating. Do not discontinue any medications without consulting a doctor.
The combined use of Ertapenem and Valeptol Solution 100 ml can reduce the blood levels of valproic acid.
How to manage the interaction:
Co-administration of Ertapenem and Valeptol Solution 100 ml can lead to an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like loss of seizure control or changes in behavior, consult your doctor immediately. Do not discontinue any medications without consulting the doctor.
Co-administration of Vorinostat with Valeptol Solution 100 ml can increase the risk of unusual bleeding.
How to manage the interaction:
Co-administration of Vorinostat and Valeptol Solution 100 ml can lead to an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, vomiting, blood in your urine or stools, headache, dizziness, or weakness, consult your doctor immediately. Do not discontinue any medications without consulting your doctor.
Co-administration of Valeptol Solution 100 ml with doripenem can reduce the blood levels of valproic acid.
How to manage the interaction:
Co-administration of Doripenam and Valeptol Solution 100 ml can lead to an interaction, it can be taken if advised by your doctor. However, if you experience sudden dizziness, lightheadedness, fainting, shortness of breath, chest pain or tightness, rapid heartbeat, involuntary muscle movements, or memory loss, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
Co-administration of Meropenam and Valeptol Solution 100 ml together can reduce the effect of Valeptol Solution 100 ml.
How to manage the interaction:
Co-administration of Meropenam and Valeptol Solution 100 ml can lead to an interaction, but it can be taken if your doctor advises. However, if you experience any unusual symptoms, consult a doctor immediately. Do not discontinue any medications without consulting a doctor.
Co-administration of Ketamine and Valeptol Solution 100 ml can increase side effects and cause respiratory depression.
How to manage the interaction:
Co-administration of Ketamine and Valeptol Solution 100 ml can lead to an interaction, but it can be taken if your doctor advises. However, consult your doctor immediately if you experience any symptoms like dizziness, drowsiness, confusion, difficulty concentrating, excessive sedation, impaired thinking, judgment, and motor coordination. Avoid driving or operating hazardous machinery until you know how these medications affect you. Do not discontinue any medications without consulting the doctor.
Using buprenorphine together with Valeptol Solution 100 ml may increase the risk of severe side effects, including respiratory problems and loss of consciousness.
How to manage the interaction:
Although the administration of buprenorphine alongside Valeptol Solution 100 ml can result in an interaction, it can be taken if a doctor has advised it. However, if you experience sudden dizziness, lightheadedness, fainting, shortness of breath, chest pain or tightness, rapid heartbeat, or memory loss, contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
Co-administration of Teriflunomide and Valeptol Solution 100 ml can increase the risk of causing liver problems.
How to manage the interaction:
Co-administration of Teriflunomide and Valeptol Solution 100 ml can lead to an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, abdominal pain, dark-colored urine, light-colored stools, and yellowing of the skin or eyes. Avoid alcohol while taking these medications, and consult your doctor immediately. Do not discontinue any medications without consulting your doctor.
Drug-Food Interactions
Drug-Food Interactions
Login/Sign Up
Valeptol Solution Substitute
Cotwel-Cr 200Mg Tablet 10'S
by AYUR
₹4.05per tabletAlporate 200Mg Syp 200Ml
by AYUR
₹0.55per tabletCognirex-Od 250Mg Tablet
by AYUR
₹4.23per tabletDilpra 250Mg Tablet
by AYUR
₹3.96per tabletValpotex-CR 200mg Tablet 10's
₹9.32per tablet
Product Substitutes
Alcohol
Caution
Do not consume alcohol while taking Valeptol Solution as alcohol can worsen the side effects of the Valeptol Solution , including sleepiness and dizziness.
Pregnancy
Unsafe
Valeptol Solution is a Category D pregnancy drug. It is not recommended for use during pregnancy as it may cause an increase in the risk of a cleft lip, which is a congenital disability in the unborn baby. If you are a female able to have a baby, you must use an effective method of birth control (contraception) without interruption during your entire treatment with Valeptol Solution .
Breast Feeding
Caution
Valeptol Solution passes into breast milk and may harm your infant. Please consult a doctor if you are breastfeeding before taking Valeptol Solution . Breastfed infants are at risk for valproic acid-induced hepatotoxicity, so infants should be monitored for jaundice and other signs of liver damage during maternal therapy.
Driving
Caution
Valeptol Solution may cause dizziness, drowsiness or tiredness in some people. Therefore, avoid driving if you feel drowsy, dizzy or tired after taking Valeptol Solution .
Liver
Caution
Inform your doctor before receiving the Valeptol Solution if you have a history of liver diseases/conditions. Extreme caution is recommended in patients with impaired liver function. Your doctor will weigh the benefits and potential risks before prescribing Valeptol Solution .
Kidney
Caution
Dose adjustment may be needed in patients with kidney impairment. Please inform your doctor if you have kidney impairment.
Children
Consult your doctor
Use is not recommended for children less than ten years. Your doctor will decide the dose based on your child's condition if more than ten years.
Disclaimer
Author Details
